cbdMD annual meeting elects directors, authorizes reverse split; appoints new Chairman, President, CFO

Proposal 2: The appointment of Cherry Bekaert LLP as our independent registered public accounting firm was ratified, based upon the following final tabulation of votes: “For ” “Against ” “Abstain ” 29,188,087 80,516 694,108

Proposal 3: The amendment to our Articles of Incorporation, as amended, at the discretion of the board of directors, to effect a reverse stock split of our issued and outstanding shares of common stock, at a specific ratio, ranging from one-for-twenty (1:20) to one-for-fifty (1:50), at any time prior to the one-year anniversary date of the annual meeting, with the exact ratio to be determined by the board was approved, based upon the following final tabulation of votes: “For ” “Against ” “Abstain ” 26,518,758 3,437,896 6,057

Proposal 1: The following directors were elected at the 2023 annual meeting of shareholders to hold office until the 2024 annual meeting of shareholders or their earlier resignation, removal or death: Directors “For ” “Against ” Broker Non-Votes Bakari Sellers 26,273,192 3,119,747 569,772 William F. Raines, III 26,321,975 3,070,914 569,772 Scott G. Stephen 26,195,800 3,197,089 569,772 Dr. Sibyl Swift 26,887,466 2,505,473 569,772